BIOLASE, Inc. (BIOLQ)

Market Cap	508.70K
Revenue (ttm)	46.03M
Net Income (ttm)	-15.97M
Shares Out	36.60M
EPS (ttm)	-0.71
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	71,843
Average Volume	53,219
Open	0.0095
Previous Close	0.0100
Day's Range	0.0095 - 0.0139
52-Week Range	0.0040 - 0.2000
Beta	0.02
RSI	57.79
Earnings Date	Mar 21, 2025

About BIOLASE

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; di...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 157
• Stock Exchange: OTCMKTS
• Ticker Symbol: BIOLQ

Financial Performance

In 2023, BIOLASE's revenue was $49.16 million, an increase of 1.45% compared to the previous year's $48.46 million. Losses were -$37.62 million, 30.4% more than in 2022.